Brief: Chimeric Therapeutics Says Board & Management Commit To A$1.04M Placement
15/05/2023 02:33
May 15 (Reuters) - Chimeric Therapeutics Ltd CHM.AX :
* BOARD & MANAGEMENT COMMIT TO A$1.04M PLACEMENT AT A$0.046
PER
SHARE
* INTENDS TO UNDERTAKE A SHARE PURCHASE PLAN RAISING UP TO A
FURTHER A$5.25M
Source text for Eikon: ID:nASX4HnVc5
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial